activated microglia
Showing 1 - 25 of 1,717
Glioblastoma Trial (PET imaging)
Not yet recruiting
- Glioblastoma
- PET imaging
- (no location specified)
Feb 23, 2023
Using IMC to Analyze the Impact of ICANS on Microglia
Recruiting
- ICANS, Grade Unspecified
- CAR T-Cell-Related Encephalopathy Syndrome
- There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Apr 12, 2023
Microglia Activation in Asthma
Recruiting
- Asthma
- Whole lung antigen challenge (WLAC)
- [18F]FEPPA
-
Madison, WisconsinUniversity of Wisconsin Madison
Jul 14, 2022
Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)
Recruiting
- Alzheimer Disease
-
New York, New YorkColumbia University Irving Medical Center
Jan 10, 2022
Measuring Active Microglia in Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
- [C11]PK-1195 PET scan
-
New York, New YorkWeill Cornell Medical College
Jan 14, 2022
Myocardial Infarction Trial in Birmingham ([18F]DPA-714-PET/MRI)
Recruiting
- Myocardial Infarction
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Medical Center
Aug 25, 2022
Microglial Activation inMS Patient Cohort at Risk of Progression
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
X Fragile Syndrome Trial in Malaga (Vitamin C 10mg/Kg Vitamin E 10 mg/Kg, Placebo)
Completed
- X Fragile Syndrome
- Vitamin C 10mg/Kg Vitamin E 10 mg/Kg
- Placebo
-
Malaga, Málaga, SpainHospital Regional de Málaga
Jul 21, 2022
Microglial Activation in the CNS
Active, not recruiting
- Multiple Sclerosis
- Imaging
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City
Recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- Ferumoxytol infusion
- +2 more
-
Salt Lake City, UtahUniversity of Utah Health Imaging and Neurosciences Center
Jun 22, 2022
Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)
Enrolling by invitation
- Epileptic Seizures Related to Drugs
-
Xi'an, Shaanxi, ChinaXijingHospital
Jul 21, 2023
Does Microglial Activation Promote Lesion Growth and Progression
Enrolling by invitation
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Nov 1, 2022
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Measurement of QSM Signal (Quantitative Susceptibility Mapping)
Recruiting
- White Matter Hyperintensity
- Multiple Sclerosis
- MRI
-
Paris, FranceHhopital fondation adolphe de rothschild
Aug 11, 2022
Neurotropism and Neuroinflammation in COVID-19 Delirium.
Recruiting
- Covid19
- +2 more
- serology testing profiles description
- +4 more
-
Toulouse, France
- +1 more
Sep 3, 2021
Parkinson's Disease Trial in Augusta (Niacin, Niacinamide, Placebo)
Active, not recruiting
- Parkinson's Disease
- Niacin
- +2 more
-
Augusta, GeorgiaCharlie Norwood VA Medical Center, Augusta, GA
Mar 8, 2022
Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)
Not yet recruiting
- Alzheimer Disease
- Placebo
- +2 more
-
Paris, FranceInstitut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022
Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)
Recruiting
- Schizophrenia
- Natalizumab
- Placebo: normal saline
-
London, United KingdomInstitute of Psychiatry, Psychology and Neuroscience, King's Col
Sep 27, 2022
Frontotemporal Dementia Trial in London ((18F)-FEPPA)
Recruiting
- Frontotemporal Dementia
- (18F)-FEPPA
-
London, Ontario, CanadaParkwood Institute
Sep 2, 2020
Critical Asymptomatic Carotid Artery Disease, Non-Critical Asymptomatic Carotid Artery Disease Trial in Birmingham
Recruiting
- Critical Asymptomatic Carotid Artery Disease
- Non-Critical Asymptomatic Carotid Artery Disease
-
Birmingham, AlabamaUAB
Dec 13, 2022
Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Hydroxychloroquine Pill
- Indapamide Pill
-
Calgary, Alberta, CanadaFoothills Medical Centre
May 16, 2022
Parkinson Disease Trial in Birmingham (DPA-714-PET/MRI)
Recruiting
- Parkinson Disease
-
Birmingham, AlabamaUAB Advanced Imaging Facility
Mar 29, 2022
Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis Trial in Birmingham (DPA-714 PET/MRI)
Recruiting
- Fibromyalgia
- +3 more
- DPA-714 PET/MRI
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Medical Center
Dec 3, 2021
Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of
Recruiting
- Intracerebral Hemorrhage
- +4 more
- Fingolimod 0.5 mg
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 28, 2022